風邪・インフルエンザサプリメント市場：タイプ、形態、流通チャネル別-2025-2030年世界予測

風邪・インフルエンザサプリメント市場は、2023年に167億8,000万米ドルと評価され、2024年には185億7,000万米ドルに達すると予測され、CAGR 10.90％で成長し、2030年には346億5,000万米ドルに達すると予測されています。

風邪とインフルエンザのサプリメント市場には、免疫機能を強化し、一般的な風邪やインフルエンザに関連する症状を緩和するように設計された栄養製品が含まれます。これらのサプリメントには、ビタミン、ミネラル、ハーブ、アミノ酸が含まれることが多く、全体的な免疫の健康をサポートし、症状の重篤度を緩和するように処方されることが多いです。これらのサプリメントは、特に秋や冬などのピークシーズンに、ウイルス感染を予防し、より迅速に回復するために重要であると考えられています。これらのサプリメントの用途は、子供、大人、高齢者など、さまざまな消費者層に広がっており、エンドユーザーは、健康志向の高い人から、従来の医療と並行して代替療法を求める人まで幅広いです。

この市場は、特に免疫回復力を強調する最近の世界の健康危機の後、健康に対する意識の高まりによって繁栄しています。予防ヘルスケアと天然サプリメントに対する動向が、オンライン販売チャネルの市場拡大とともに大きな成長を牽引しています。製剤の革新と個別化栄養のトレンドの高まりは、製品開発に新たな道を開き、より個別化された消費者体験に対応しています。こうした成長要因にもかかわらず、市場は規制上のハードル、製品の有効性の臨床的検証の必要性、医薬品との競合など、大きな課題に直面しています。一部のサプリメントの有効性に関する消費者の懐疑的な見方は、市場力学をさらに複雑にしています。

潜在的なビジネスチャンスは、研究とイノベーション、特に健康効果が実証された科学的裏付けのあるサプリメントの開発にあります。企業は、製品の信頼性を高める革新的なマーケティング戦略や消費者教育イニシアティブのために、デジタル・プラットフォームを活用することができます。さらに、新興市場に進出することで、予防ヘルスケア・ソリューションへの投資を厭わない、より幅広い消費者層へのアクセスが可能になります。しかし、企業は規制上の課題を軽減し、消費者の懐疑心を克服するために、表示の透明性を維持し、実質的な科学的証拠を収集する必要があります。この市場は、成長を持続させ、効果的な健康介入を求める消費者の信頼を確立するために、継続的なイノベーション、消費者の関与、確かな臨床研究への集中を必要としています。

市場力学：急速に進化する風邪・インフルエンザサプリメント市場の主要市場インサイトを公開

風邪・インフルエンザサプリメント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 季節性疾病の流行と高齢化社会の免疫健康への懸念
  • 政府の健康プログラムやイニシアティブを通じた消費者の意識の高まり
  • 天然サプリメントやハーブサプリメントへの嗜好の高まり
• 市場抑制要因
  • 医薬品の代替品の普及
• 市場機会
  • 新開発の免疫力向上サプリメントの継続的なイントロダクション
  • スーパーマーケットやオンライン販売チャネルの拡大
• 市場の課題
  • 製品の品質維持と規制要件の遵守に関する課題

ポーターの5つの力：風邪・インフルエンザサプリメント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：風邪・インフルエンザサプリメント市場における外部からの影響の把握

外部マクロ環境要因は、風邪・インフルエンザサプリメント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析風邪・インフルエンザサプリメント市場における競合情勢の把握

風邪・インフルエンザサプリメント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス風邪・インフルエンザサプリメント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、風邪・インフルエンザサプリメント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨風邪・インフルエンザサプリメント市場における成功への道筋を描く

風邪・インフルエンザサプリメント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 季節性疾患の発生と高齢者の免疫健康への懸念
    • 政府の健康プログラムや取り組みを通じて消費者の意識が高まる
    • 天然およびハーブサプリメントへの新たな嗜好
  • 抑制要因
    • 医薬品代替品のより広範な利用可能性
  • 機会
    • 新たに開発された免疫力増強サプリメントの継続的なイントロダクション
    • スーパーマーケットとオンライン流通チャネルの拡大
  • 課題
    • 製品の品質を維持し、規制要件を遵守することに伴う課題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 風邪・インフルエンザサプリメント市場：タイプ別

• ハーブエキス
• ホメオパシー
• 天然分子
• ビタミンとミネラル

第7章 風邪・インフルエンザサプリメント市場：形態別

• 錠剤とカプセル
• 粉末
• シロップ

第8章 風邪・インフルエンザサプリメント市場：流通チャネル別

• オンラインおよびeコマースプラットフォーム
• 薬局・ドラッグストア

第9章 南北アメリカの風邪・インフルエンザサプリメント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の風邪・インフルエンザサプリメント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの風邪・インフルエンザサプリメント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amway International Inc.
• Bayer AG
• Church & Dwight Co., Inc.
• GlaxoSmithKline PLC
• Haleon PLC
• Himalaya Global Holdings Ltd.
• Johnson & Johnson Services Inc.
• Medique Products
• Mondelez Global LLC
• Nature's Sunshine Products, Inc.
• Nature's Way, Inc.
• Neurobiologix, Inc.
• Nutraceutical Corporation
• Perrigo Company PLC
• Reckitt Benckiser Group PLC
• Sambucol by PharmaCare Laboratories Pty Ltd.
• Sun Pharmaceutical Industries Ltd.
• The Menarini Group
• The Procter & Gamble Company
• Thornton and Ross Limited by STADA Group
• Wakunaga Pharmaceutical Co., Ltd.

LIST OF FIGURES

• FIGURE 1. COLD & FLU SUPPLEMENTS MARKET RESEARCH PROCESS
• FIGURE 2. COLD & FLU SUPPLEMENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COLD & FLU SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COLD & FLU SUPPLEMENTS MARKET DYNAMICS
• TABLE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HOMEOPATHIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY NATURAL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PILLS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE & E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 31. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 48. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 51. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 103. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 115. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 118. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Cold & Flu Supplements Market was valued at USD 16.78 billion in 2023, expected to reach USD 18.57 billion in 2024, and is projected to grow at a CAGR of 10.90%, to USD 34.65 billion by 2030.

The cold and flu supplements market encompasses nutritional products designed to bolster immune function and alleviate symptoms associated with common colds and flu. These supplements often include vitamins, minerals, herbs, and amino acids, often formulated to support overall immune health and mitigate symptom severity. They are considered critical for preventing viral infections and recovering more swiftly, especially during peak seasons like fall and winter. The application of these supplements extends across different consumer demographics, including children, adults, and the elderly, with end-users ranging from health-conscious individuals to those seeking alternative solutions alongside conventional medicine.

The market thrives due to increased health awareness, especially after recent global health crises emphasizing immune resilience. The trend towards preventive healthcare and natural supplements has driven significant growth, alongside online sales channels expanding market reach. Innovations in formulation and the growing trend for personalized nutrition are opening new avenues for product development, catering to a more individualized consumer experience. Despite these growth factors, the market faces significant challenges, including regulatory hurdles, the need for clinical validation of product efficacy, and competition from pharmaceuticals. Consumer skepticism regarding the effectiveness of some supplements further complicates market dynamics.

Potential opportunities lie in research and innovation, particularly in the development of scientifically backed supplements with proven health benefits. Companies can leverage digital platforms for innovative marketing strategies and consumer education initiatives that enhance product credibility. Additionally, expanding into emerging markets can provide access to a broader consumer base willing to invest in preventative healthcare solutions. However, companies need to maintain transparency in labeling and gather substantive scientific evidence to mitigate regulatory challenges and overcome consumer skepticism. This market demands continuous innovation, consumer engagement, and a focus on robust clinical research to sustain growth and establish trust among consumers seeking effective health interventions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold & Flu Supplements Market

The Cold & Flu Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Seasonal disease outbreaks and concerns about immune health of aging population
  • Rising consumer awareness through government health programs and initiatives
  • Emerging preferences for natural and herbal supplements
• Market Restraints
  • Wider availability of pharmaceutical alternatives
• Market Opportunities
  • Ongoing introduction of newly developed immunity booster supplements
  • Growing expansion of supermarkets and online distribution channels
• Market Challenges
  • Challenges associated with maintaining product quality and adhering to regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the Cold & Flu Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold & Flu Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold & Flu Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold & Flu Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold & Flu Supplements Market

A detailed market share analysis in the Cold & Flu Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold & Flu Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold & Flu Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold & Flu Supplements Market

A strategic analysis of the Cold & Flu Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold & Flu Supplements Market, highlighting leading vendors and their innovative profiles. These include Amway International Inc., Bayer AG, Church & Dwight Co., Inc., GlaxoSmithKline PLC, Haleon PLC, Himalaya Global Holdings Ltd., Johnson & Johnson Services Inc., Medique Products, Mondelez Global LLC, Nature's Sunshine Products, Inc., Nature's Way, Inc., Neurobiologix, Inc., Nutraceutical Corporation, Perrigo Company PLC, Reckitt Benckiser Group PLC, Sambucol by PharmaCare Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., The Menarini Group, The Procter & Gamble Company, Thornton and Ross Limited by STADA Group, and Wakunaga Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cold & Flu Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Herbal Extracts, Homeopathic, Natural Molecules, and Vitamins & Minerals.
• Based on Form, market is studied across Pills & Capsules, Powders, and Syrups.
• Based on Distribution Channel, market is studied across Online & E-commerce Platforms and Pharmacies & Drug Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Seasonal disease outbreaks and concerns about immune health of aging population
    • 5.1.1.2. Rising consumer awareness through government health programs and initiatives
    • 5.1.1.3. Emerging preferences for natural and herbal supplements
  • 5.1.2. Restraints
    • 5.1.2.1. Wider availability of pharmaceutical alternatives
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing introduction of newly developed immunity booster supplements
    • 5.1.3.2. Growing expansion of supermarkets and online distribution channels
  • 5.1.4. Challenges
    • 5.1.4.1. Challenges associated with maintaining product quality and adhering to regulatory requirements
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cold & Flu Supplements Market, by Type

• 6.1. Introduction
• 6.2. Herbal Extracts
• 6.3. Homeopathic
• 6.4. Natural Molecules
• 6.5. Vitamins & Minerals

7. Cold & Flu Supplements Market, by Form

• 7.1. Introduction
• 7.2. Pills & Capsules
• 7.3. Powders
• 7.4. Syrups

8. Cold & Flu Supplements Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Online & E-commerce Platforms
• 8.3. Pharmacies & Drug Stores

9. Americas Cold & Flu Supplements Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cold & Flu Supplements Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cold & Flu Supplements Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amway International Inc.
• 2. Bayer AG
• 3. Church & Dwight Co., Inc.
• 4. GlaxoSmithKline PLC
• 5. Haleon PLC
• 6. Himalaya Global Holdings Ltd.
• 7. Johnson & Johnson Services Inc.
• 8. Medique Products
• 9. Mondelez Global LLC
• 10. Nature's Sunshine Products, Inc.
• 11. Nature's Way, Inc.
• 12. Neurobiologix, Inc.
• 13. Nutraceutical Corporation
• 14. Perrigo Company PLC
• 15. Reckitt Benckiser Group PLC
• 16. Sambucol by PharmaCare Laboratories Pty Ltd.
• 17. Sun Pharmaceutical Industries Ltd.
• 18. The Menarini Group
• 19. The Procter & Gamble Company
• 20. Thornton and Ross Limited by STADA Group
• 21. Wakunaga Pharmaceutical Co., Ltd.